SEC Flags Safety, Efficacy Gaps in Troikaa’s Rapid IV Paracetamol Bolus Proposal, Seeks More Data
New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has declined to approve Troikaa Pharmaceuticals' proposed Paracetamol 1000 mg/4 ml intravenous bolus injection, citing…
